Gerry Garcia, Invitrogen Corporation

With worldwide operations and annual revenue exceeding $1.26 billion, Invitrogen Corporation provides products and services to pharmaceutical and biotechnology companies, as well as to academic and government research institutions. It employs more than 5,000 people in over 70 countries.

M² engagements for Invitrogen have spanned the functional areas of finance, information technology, internal audits, sales, and service and have included large initiatives such as Sarbanes-Oxley (SOX) compliance preparation and Enterprise Resource Planning (ERP) implementation. "Sarbanes-Oxley was a difficult, high-stakes project," says Gerry Garcia, Invitrogen's audit director, "but M²'s experts deftly guided us through it and left us with a solid foundation that we still use today."

Invitrogen depends on the quality of the consultants and M²'s knowledge of its business. "I've seen M² consultants work at the highest levels of the organization," he says, "and they have the skills to engage stakeholders, reconcile conflicting agendas, and successfully drive tough change through a complex business."